Interactive worksheet
Interactive calculator
Clinical inputs
0/7 filled
Clinical contextWhy this tool matters and how to interpret it
Understand the result,
not just the number.
PAMI Risk Score: Comprehensive Explanation and Clinical Context The PAMI (Primary Angioplasty in Myocardial Infarction) Risk Score is a clinical tool developed to predict 30-day mortality in patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). It uses seven readily available clinical variables: age, comorbidities, heart rate, systolic blood pressure, Killip class, infarct location, and delay to treatment. Higher scores indicate increased short-term mortality risk and the need for more intensive monitoring and supportive therapy.
The PAMI Score remains a useful bedside tool despite the evolution of PCI technology and adjunctive pharmacotherapy.
Evidence & references3 primary sources mapped
- Source 1
Addala S, Grines CL, Dixon SR, et al. Predicting mortality in patients with STEMI undergoing primary angioplasty: the PAMI Risk Score. Am J Cardiol. 2004;93(5):629–632.
- Source 2
Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med. 1993;328(10):673–679.
- Source 3
Mehta RH, et al. Risk assessment in acute coronary syndromes and the role of risk scores. Am Heart J. 2007;154(1):21–28.
Clinical discussionModerated, tool-specific conversation
Loading discussion…